This SBRI competition aims to accelerate and/or increase the development and adoption of innovative diagnostic tools in order to offer better targeted treatment to patients within the UK healthcare system. It also aims to demonstrate the benefits of companies working within the UK ‘enabling infrastructure’, which is made up of specialist organisations that can help companies understand healthcare needs and design, evaluate and deliver their products and services into the NHS.
Up to £2m is available for phase 1 of the competition and up to a further £8m may be available in a second phase to further develop successful phase 1 projects. The competition is open to all organisations that can demonstrate a route to market for their solution. Successful organisations will attract a 100% funded development contract of up to £150,000 over nine months in phase 1, with the potential to apply for up to £2m over a further three years in phase 2.
We will support projects that seek to develop tests capable of classifying patients into groups and selecting them for a clinical treatment (or treatments) currently available in the UK.
We are looking to fund projects that include the following:
a diagnostic test that will lead to better treatment for patients
a description of how the company will interact with ‘enabling’ organisations within the UK to overcome barriers to adoption of their product, including changes to clinical care pathways where appropriate
an initial draft of the development plan for preparing the product for market (this will need to be in more depth in phase 2)
Out of scope
In this competition we are not funding projects covering:
the development of diagnostic tests that do not give rise to patient stratification
diagnostic tests for treatments that are still in development
biomarker discovery experiments
|Competition opens||7 September 2015|
|Briefing event||15 September 2015|
|Registration deadline||28 October 2015 noon|
|Deadline for applications||4 November 2015 noon|
|Contracts awarded||January 2016|
Please visit Innovate UK for the full article